GRIFFON Pharmaceuticals
Griffon Pharma is an early stage biotechnology company developing next-generation long-acting peptide therapeutics for obesity and related cardiometabolic diseases.
Our goal is to reduce the physical and emotional burden of cardiometabolic disease.